B Group, Inc. Adma Biologics, Inc. Transaction History
B Group, Inc.
- $117 Billion
- Q1 2025
A detailed history of B Group, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, B Group, Inc. holds 2,317,542 shares of ADMA stock, worth $46 Million. This represents 39.39% of its overall portfolio holdings.
Number of Shares
2,317,542
Previous 2,287,542
1.31%
Holding current value
$46 Million
Previous $39.2 Billion
17.2%
% of portfolio
39.39%
Previous 23.98%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
379Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$370 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$334 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$255 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$227 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$112 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.9B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...